National Academies Press: OpenBook
« Previous: Appendix B: State Plans
Suggested Citation:"Appendix C: Meeting One Agenda." Institute of Medicine. 2008. Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program. Washington, DC: The National Academies Press. doi: 10.17226/12170.
×
Page 107
Suggested Citation:"Appendix C: Meeting One Agenda." Institute of Medicine. 2008. Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program. Washington, DC: The National Academies Press. doi: 10.17226/12170.
×
Page 108
Suggested Citation:"Appendix C: Meeting One Agenda." Institute of Medicine. 2008. Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program. Washington, DC: The National Academies Press. doi: 10.17226/12170.
×
Page 109
Suggested Citation:"Appendix C: Meeting One Agenda." Institute of Medicine. 2008. Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program. Washington, DC: The National Academies Press. doi: 10.17226/12170.
×
Page 110
Suggested Citation:"Appendix C: Meeting One Agenda." Institute of Medicine. 2008. Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program. Washington, DC: The National Academies Press. doi: 10.17226/12170.
×
Page 111
Suggested Citation:"Appendix C: Meeting One Agenda." Institute of Medicine. 2008. Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program. Washington, DC: The National Academies Press. doi: 10.17226/12170.
×
Page 112

Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Appendix C Meeting One Agenda Committee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic Meeting 1 December 3–4, 2007 National Academy of Sciences Building 2101 Constitution Avenue, NW Washington, DC AGENDA December 3, 2007 Auditorium 1:00 pm Welcome, Committee Introductions, and Opening Comments June Osborn Committee Chair Background 1:15 pm Charge to the Committee  Guidance on Use of Antiviral Drugs and Planning Assumptions Benjamin Schwartz Senior Science Advisor National Vaccine Program Office Department of Health and Human Services 1:45 pm Committee Questions 107

108 ANTIVIRALS FOR PANDEMIC INFLUENZA 2:15 pm Primer on Antiviral Drug Effectiveness and Resistance Fred Hayden World Health Organization Professor of Internal Medicine and Pathology Department of Medicine Division of Infectious Diseases and International Health University of Virginia Health System Infectious Diseases Society of America 2:45 pm Committee Questions 3:00 pm Antiviral Drug Stockpiling and Distribution Planning Anita Patel Health Scientist Lockheed Martin Information Technology Contractor assigned to Division of Strategic National Stockpile  Coordinating Office of Terrorism Preparedness and Emergency Response Centers for Disease Control and Prevention 3:15 pm Committee Questions 3:30 pm Legal Issues in an Influenza Pandemic James G. Hodge Associate Professor Johns Hopkins Bloomberg School of Public Health Executive Director and Principal Investigator  Centers for Law and the Public’s Health: A Collaborative Core Faculty, Johns Hopkins Berman Institute of Bioethics 3:45 pm Committee Questions 4:00 pm Break Panel 1: Diagnosing Influenza 4:15 pm Diagnosis in Children John Bradley Director of the Division of Infectious Diseases  Children’s Hospital, San Diego American Academy of Pediatrics Infectious Diseases Society of America

APPENDIX C 109 4:30 pm Diagnosis in Adults Andrew Pavia George and Esther Gross Presidential Professor  Chief of the Division of Pediatric Infectious Diseases University of Utah Health Sciences Center and Primary Children’s of Utah Infectious Diseases Society of America Member of the Institute of Medicine Committee 4:45 pm Other Diagnostic Issues Marie Griffin Professor of Preventive Medicine Professor of Medicine Vanderbilt University School of Medicine 5:00 pm Infection Control in the Waiting Room Richard Clover Dean School of Public Health and Information Sciences University of Louisville 5:15 pm Committee Questions and Discussion with Panel 5:45 pm Adjourn December 4, 2007 Lecture Room 8:00 am Welcome June Osborn Committee Chair Panel 2: Treating Cases and Providing Post-Exposure Prophylaxis to Their Household Contacts 8:15 am Federal, State, and Local Laws Regarding Prescribing and Dispensing Stephen W. Schondelmeyer Chair Department of Pharmaceutical Care Health Care Systems Professor of Pharmaceutical Economics  Century Mortar Club Endowed Chair in Pharmaceutical Management University of Minnesota

110 ANTIVIRALS FOR PANDEMIC INFLUENZA 8:30 am Federal Regulatory Perspective Barbara A. Styrt Medical Officer Division of Antiviral Drug Products Office of Antimicrobial Products Office of New Drugs Center for Drug Evaluation and Research Food and Drug Administration 8:45 am Role of Pharmacies Catherine M. Polley Vice President Pharmacy Services Food Marketing Institute 9:00 am Other Issues Related to Dispensing Prophylaxis Tammy Robertson Operations Manager, Fedex Custom Critical 9:15 am Committee Questions and Discussion with Panel 9:45 am Break Panel 3: State and Local Planning 10:00 am State Planning (overview, considerations, and examples) Donald E. Williamson Health Officer Alabama State Department of Health 10:30 am Local Planning (overview, considerations, and examples) Jane Zucker Assistant Commissioner Bureau of Immunization New York City Department of Health and Mental Hygiene Paul Biedrzycki Director Disease Control and Prevention City of Milwaukee Health Department

APPENDIX C 111 Junie Delizo Director Emergency Preparedness Rockland County (NY) Department of Health 11:30 am Committee Questions and Discussion with Panel 12:00 pm Lunch Panel 4: Outbreak Prophylaxis of Health Care Workers 1:00 pm Hospital-Based Prophylaxis Allison McGeer Microbiologist, Infectious Disease Consultant Mount Sinai Hospital Toronto, Ontario Professor Departments of Laboratory Medicine and Pathobiology Department of Public Health Sciences University of Toronto Stephen R. Pitts Attending Physician, Emory Crawford Long Hospital Emergency Department Associate Professor Department of Emergency Medicine Emory University School of Medicine on sabbatical as AcademyHealth Fellow National Center for Health Statistics 1:45 pm Prophylaxis at Outpatient Sites Douglas Campos-Outcalt Clinical Professor and Associate Chair Department of Family and Community Medicine University of Arizona College of Medicine American Academy of Family Physicians 2:00 pm Long-Term Care Facilities Janice Zalen Director of Special Programs American Health Care Association

112 ANTIVIRALS FOR PANDEMIC INFLUENZA 2:30 pm Health Care Worker Labor Issues Katherine Cox Health Policy Analyst  American Federation of State, County and Municipal Employees International 2:45 pm Committee Questions and Discussion with Panel 3:00 pm Break Panel 5: Outbreak Prophylaxis in Emergency Service Organizations (fire, police, emergency medical services) 3:15 pm Emergency Medical Services (EMS) Kathy Robinson Program Advisor National Association of State EMS Officials 3:30 pm Fire John Delaney Captain Fire Department Arlington County, V A 4:00 pm Committee Questions and Discussion with Panel 4:30 pm Adjourn

Next: Appendix D: Meeting Two Agenda »
Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program Get This Book
×
Buy Paperback | $43.00 Buy Ebook | $34.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Planning for an influenza pandemic, whether it occurs in the near or distant future, will need to take into account many constantly evolving factors. The Institute of Medicine (IOM) Committee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic was asked by the Department of Health and Human Services, (DHHS) to consider best practices and policies for providing antiviral treatment and prophylaxis during a pandemic event. The committee's report, entitled Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program, calls for a national and public process of creating an ethical framework for antiviral use within the context of uncertainty and scarcity. It is unclear whether antivirals will work against a pandemic strain as well as they work against seasonal influenza. Also, government stockpiles may not be sufficient for all possible uses in part because antivirals are costly and public health agencies must invest in other important activities, including other medical resources for pandemic influenza. Furthermore, the report identifies the lack of a science-based advisory body to guide decision making during the pandemic, including guidance on all dimensions of antiviral dispensing (for example, prioritization, drug safety, and antiviral resistance). The report also acknowledges the need for diverse methods and sites of dispensing, and discusses their advantages and disadvantages.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  6. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  7. ×

    View our suggested citation for this chapter.

    « Back Next »
  8. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!